[1]
|
Kleinbongard, P., Schulz, R. and Heusch, G. (2011) TNF-alpha in myocardial ischemia/reperfusion, remodeling and heart failure. Heart Failure Reviews, 16, 46-69.
|
[2]
|
Levine, B., et al. (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. The New England Journal of Medicine, 323, 236-241.
doi:10.1056/NEJM199007263230405
|
[3]
|
Przyklenk, K., et al. (1993) Regional ischemic “preconditioning” protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation, 87, 893-899. doi:10.1161/01.CIR.87.3.893
|
[4]
|
Mann, D.L. (2002) Inflammatory mediators and the failing heart: Past, present, and the foreseeable future. Circulation Research, 91, 988-998.
doi:10.1161/01.RES.0000043825.01705.1B
|
[5]
|
Sack, M.N. and Yellon, D.M. (2003) Insulin therapy as an adjunct to reperfusion after acute coronary ischemia: A proposed direct myocardial cell survival effect independent of metabolic modulation. Journal of the American College of Cardiology, 41, 1404-1407.
doi:10.1016/S0735-1097(03)00164-5
|
[6]
|
Deuchar, G.A., Opie, L.H. and Lecour, S. (2007) TNFalpha is required to confer protection in an in vivo model of classical ischaemic preconditioning. Life Science, 80, 1686-1691. doi:10.1016/j.lfs.2007.01.040
|
[7]
|
Lecour, S., Rochette, L. and Opie, L. (2005) Free radicals trigger TNF alpha-induced cardioprotection. Cardiovascular Research, 65, 239-243.
doi:10.1016/j.cardiores.2004.10.003
|
[8]
|
Kaloustian, S., et al. (2009) Tumor necrosis factor-alpha participates in apoptosis in the limbic system after myocardial infarction. Apoptosis, 14, 1308-1316.
doi:10.1007/s10495-009-0395-x
|
[9]
|
Maekawa, N., et al. (2002) Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-alpha. Journal of the American College of Cardiology, 39, 1229-1235.
doi:10.1016/S0735-1097(02)01738-2
|
[10]
|
Bradley, J.R. (2008) TNF-mediated inflammatory disease. Journal of Pathology, 214, 149-160.
doi:10.1002/path.2287
|
[11]
|
Boucher, M., et al. (2002) Alterations of beta-adrenoceptor responsiveness in postischemic myocardium after 72 h of reperfusion. European Journal of Pharmacology, 495, 185-191. doi:10.1016/j.ejphar.2004.05.040
|
[12]
|
Wann, B.P., et al. (2006) Apoptosis detected in the amygdala following myocardial infarction in the rat. Biological Psychiatry, 59, 430-433.
doi:10.1016/j.biopsych.2005.07.018
|
[13]
|
Boucher, M., et al. (2006) Reduction of apoptosis in the amygdala by an A2A adenosine receptor agonist following myocardial infarction. Apoptosis, 11, 1067-1074.
doi:10.1007/s10495-006-6313-6
|
[14]
|
Belosjorow, S., et al. (2003) TNF-a antibodies are as effective as ischemic preconditioning in reducing infarct size in rabbits. American Journal of Physiology, 284, H927-H930.
|
[15]
|
Gu, Q., et al. (2006) Inhibition of TNF-alpha reduces myocardial injury and proinflammatory pathways following ischemia-reperfusion in the dog. Journal of Cardiovascular Pharmacology, 48, 320-328.
doi:10.1097/01.fjc.0000250079.46526.38
|
[16]
|
Sugano, M., et al. (2004) In vivo transfer of soluble TNF-alpha receptor 1 gene improves cardiac function and reduces infarct size after myocardial infarction in rats. FASEB Journal, 18, 911-913.
|
[17]
|
Lecour, S., et al. (2002) Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection. Journal of Molecular and Cellular Cardiology, 34, 509-518.
doi:10.1006/jmcc.2002.1533
|
[18]
|
Duran, W.N. (2008) The double-edge sword of TNF-alpha in ischemia-reperfusion injury. American Journal of Physiology—Heart and Circulatory Physiology, 295, H2221-H2222. doi:10.1152/ajpheart.01050.2008
|
[19]
|
Reil, J.C., et al. (2007) Insights from knock-out models concerning postischemic release of TNFalpha from isolated mouse hearts. Journal of Molecular and Cellular Cardiology, 42, 133-141. doi:10.1016/j.yjmcc.2006.09.020
|
[20]
|
McVey, M., Perrone, M.H. and Clark, K.L. (1999) Does tumor necrosis factor-alpha (TNF-alpha) contribute to myocardial reperfusion injury in anesthetized rats? General Pharmacology, 32, 41-45.
doi:10.1016/S0306-3623(98)00050-0
|
[21]
|
Hausenloy, D.J., Tsang, A. and Yellon, D.M. (2005) The reperfusion injury salvage kinase pathway: A common target for both ischemic preconditioning and postconditioning. Trends in Cardiovascular Medicine, 15, 69-75.
doi:10.1016/j.tcm.2005.03.001
|
[22]
|
Lecour, S. (2009) Multiple protective pathways against reperfusion injury: A SAFE path without Aktion? Journal of Molecular and Cellular Cardiology, 46, 607-609.
doi:10.1016/j.yjmcc.2009.01.003
|
[23]
|
Boucher, M., et al. (2004) Post-ischemic cardioprotection by A2A adenosine receptors: Dependent of phosphatidylinositol 3-kinase pathway. Journal of Cardiovascular Pharmacology, 43, 416-422.
doi:10.1097/00005344-200403000-00013
|